Chronic inflammation and cancer are mutually intertwined conditions, both driven by activation of common signaling pathways including signaling via nuclear factor kappa B (NF-kB), signal transducer and activator of transcription 3 (STAT3), and mammalian target of the rapamycin (mTOR). Here, MTOR is linked to cancer.